MedPath

102 Annual Pap Smear Screening Database Maintenance Project

Conditions
Cancer
Human Papillomavirus
Registration Number
NCT02063152
Lead Sponsor
National Taiwan University Hospital
Brief Summary

This study aimed to evaluate the subsequent cancer risks, including gynecological cancers and malignancies at other sites, after the detection of screening positives and the diagnosis for primary cervical cancer.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
300000
Inclusion Criteria
  • Citizens in Taiwan
  • Women who attended screening, or who were diagnosed as cervical cancer
  • Women who did not attend screening for at least 6 years
Exclusion Criteria
  • Women died before the follow-up initiation
  • Women who had received hysterectomy before the follow-up initiation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time to the cancer diagnosis or the recurrence, the death, or the last date of follow-up, whichever came firstup to 25 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Taiwan Cervical Cancer Prevention Monitoring Center

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath